Table 2 Procedural data and outcomes
TAVI with BAV | TAVI without BAV | P-value | |||
|---|---|---|---|---|---|
N | Value | N | Value | ||
Valve size | 339 | 355 | < 0.001 | ||
20–23 mm | 28.9 | 31.0 | |||
26 mm | 45.1 | 41.1 | |||
29 mm | 26.0 | 27.9 | |||
Post-delivery balloon dilation (%) | 339 | 22.4 | 355 | 15.5 | 0.020 |
Quantity contrast agent used (mL) | 303 | 100 (73–131) | 349 | 95 (70–126) | 0.343 |
Access complications (%) | 339 | 0.9 | 355 | 2.3 | 0.224 |
Hemodynamic instability (%) | 117 | 5.1 | 277 | 2.5 | 0.219 |
Catecholamine use (inotropes) (%) | 117 | 17.9 | 277 | 9.0 | 0.016 |
Effective orifice area post-surgery | 119 | 1.89 (1.59/2.30) | 114 | 1.80 (1.50/2.20) | 0.378 |
Indexed effective orifice area | 282 | 0.38 (0.31/0.46) | 251 | 0.39 (0.31/0.46) | 0.348 |
AV mean PG post-surgery | 286 | 9.0 (6.0/12.0) | 252 | 9.0 (6.0/12.8) | 0.862 |
Paravalvular regurgitation | 339 | 351 | < 0.001 | ||
None/trace | 78.5 | 84.3 | |||
Mild | 18.9 | 15.1 | |||
Moderate | 2.4 | 0.6 | |||
Severe | 0.3 | 0.0 | |||
Device success (%) | 339 | 97.9 | 355 | 99.2 | 0.214 |
Second valve needed (%) | 339 | 1.2 | 355 | 0.8 | 0.719 |
Conversion to surgery (%) | 141 | 3.5 | 280 | 2.1 | 0.518 |
Coronary artery obstruction requiring intervention (%) | 213 | 0.9 | 71 | 0.0 | 1.000 |
Device malfunction (%) | 339 | 0.6 | 355 | 0.3 | 0.616 |
Atrioventricular block (%) | 339 | 4.1 | 355 | 1.4 | 0.035 |
Aortic root rupture (%) | 339 | 0.3 | 355 | 0.0 | 0.488 |
Correct positioning of a single prosthetic valve into the proper anatomical location | 339 | 99.1 | 355 | 99.7 | 0.363 |
Intended performance of the prosthetic valve | 287 | 97.9 | 217 | 98.6 | 0.738 |